HISTOGENICS CORP - COM (HSGX)

CUSIP: 43358V109

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM
Total 13F shares
10,515,820
Share change
+957,079
Total reported value
$6,947,000
Price per share
$0.12
Number of holders
19
Value change
+$202,258
Number of buys
7
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 43358V109?
CUSIP 43358V109 identifies HSGX - HISTOGENICS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HISTOGENICS CORP - COM (HSGX) as of Q1 2019

As of 31 Mar 2019, HISTOGENICS CORP - COM (HSGX) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,515,820 shares. The largest 10 holders included VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, Abingworth LLP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, PANAGORA ASSET MANAGEMENT INC, Palo Alto Investors LP, GEODE CAPITAL MANAGEMENT, LLC, CREDIT SUISSE AG/, and Rossmore Private Capital. This page lists 19 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.